Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine

Nature Neuroscience

Volumn 18, Issue 6, 2015, Pages 883-891

  Kim, Il Hwan ^a   Rossi, Mark A ^a   Aryal, Dipendra K ^a   Racz, Bence ^b   Kim, Namsoo ^a   Uezu, Akiyoshi ^a   Fan, Wang ^a   Wetsel, William C ^a   Weinberg, Richard J ^c   Yin, Henry ^a   Soderling, Scott H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SZENT ISTVÁN UNIVERSITY   (Hungary)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN RELATED PROTEIN 2-3 COMPLEX; DOPAMINE; NEUROLEPTIC AGENT; ACTIN RELATED PROTEIN 3; ANGIOPOIETIN; ANGPTL2 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; CYTOSKELETON; DENDRITIC SPINE; FRONTAL CORTEX; LOCOMOTION; MENTAL DISEASE; MESENCEPHALON; MOUSE; NERVE CELL NETWORK; NERVE CELL STIMULATION; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RESTLESSNESS; SPINE; SPINE PRUNING; STEREOTYPY; SYNAPSE; WILD TYPE; ANIMAL; DRUG EFFECTS; FEMALE; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; MUTATION; NEOSTRIATUM; OPTOGENETICS; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; PREFRONTAL CORTEX; PSYCHOLOGY;

ACTIN-RELATED PROTEIN 3; ANGIOPOIETINS; ANIMALS; ANTIPSYCHOTIC AGENTS; DENDRITIC SPINES; DOPAMINE; FEMALE; LOCOMOTION; MALE; MESENCEPHALON; MICE; MICE, KNOCKOUT; MUTATION; NEOSTRIATUM; NERVE NET; OPTOGENETICS; PATCH-CLAMP TECHNIQUES; PREFRONTAL CORTEX; PSYCHOMOTOR AGITATION; PYRAMIDAL CELLS; STEREOTYPED BEHAVIOR;

EID: 84929881828     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.4015     Document Type: Article

References (54)

1. Purcell, S.M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185-190 (2014).
2. Lee, S.H. et al. Estimating the proportion of variation in susceptibility to schizophrenia captured by common SNPs. Nat. Genet. 44, 247-250 (2012).
3. Malhotra, D. & Sebat, J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell 148, 1223-1241 (2012).
4. Stergiakouli, E. et al. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am. J. Psychiatry 169, 186-194 (2012).
5. McCarroll, S.A. & Hyman, S.E. Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology. Neuron 80, 578-587 (2013).
6. Hyman, S.E. Perspective: revealing molecular secrets. Nature 508, S20 (2014).
7. Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184 (2014).
8. Kirov, G. et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17, 142-153 (2012).
9. Chang, J., Gilman, S.R., Chiang, A.H., Sanders, S.J. & Vitkup, D. Genotype to phenotype relationships in autism spectrum disorders. Nat. Neurosci. 18, 191-198 (2015).
10. Han, K. et al. SHANK3 overexpression causes manic-like behaviour with unique pharmacogenetic properties. Nature 503, 72-77 (2013).
11. Durand, C.M. et al. SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism. Mol. Psychiatry 17, 71-84 (2012).
12. Won, H. et al. GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice. Nat. Med. 17, 566-572 (2011).
13. Hayashi-Takagi, A. et al. Disrupted-in-Schizophrenia 1 (DISC1) regulates spines of the glutamate synapse via Rac1. Nat. Neurosci. 13, 327-332 (2010).
14. Carlson, B.R. et al. WRP/srGAP3 facilitates the initiation of spine development by an inverse F-BAR domain, and its loss impairs long-Term memory. J. Neurosci. 31, 2447-2460 (2011).
15. Govek, E.E. et al. The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nat. Neurosci. 7, 364-372 (2004).
16. Meng, Y. et al. Abnormal spine morphology and enhanced LTP in LIMK-1 knockout mice. Neuron 35, 121-133 (2002).
17. Gu, Z., Jiang, Q., Fu, A.K., Ip, N.Y. & Yan, Z. Regulation of NMDA receptors by neuregulin signaling in prefrontal cortex. J. Neurosci. 25, 4974-4984 (2005).
18. De Rubeis, S. et al. CYFIP1 coordinates mRNA translation and cytoskeleton remodeling to ensure proper dendritic spine formation. Neuron 79, 1169-1182 (2013).
19. Clement, J.P. et al. Pathogenic SYNGAP1 mutations impair cognitive development by disrupting maturation of dendritic spine synapses. Cell 151, 709-723 (2012).
20. Russell, T.A. et al. A sequence variant in human KALRN impairs protein function and coincides with reduced cortical thickness. Nat. Commun. 5, 4858 (2014).
21. Vaags, A.K. et al. Absent CNKSR2 causes seizures and intellectual, attention, and language deficits. Ann. Neurol. 76, 758-764 (2014).
22. Koleske, A.J. Molecular mechanisms of dendrite stability. Nat. Rev. Neurosci. 14, 536-550 (2013).
23. Penzes, P., Cahill, M.E., Jones, K.A., VanLeeuwen, J.E. & Woolfrey, K.M. Dendritic spine pathology in neuropsychiatric disorders. Nat. Neurosci. 14, 285-293 (2011).
24. Mullins, R.D., Stafford, W.F. & Pollard, T.D. Structure, subunit topology, and actin-binding activity of the Arp2/3 complex from Acanthamoeba. J. Cell Biol. 136, 331-343 (1997).
25. Kim, I.H. et al. Disruption of Arp2/3 results in asymmetric structural plasticity of dendritic spines and progressive synaptic and behavioral abnormalities. J. Neurosci. 33, 6081-6092 (2013).
26. van den Buuse, M. Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr. Bull. 36, 246-270 (2010).
27. Mohn, A.R., Gainetdinov, R.R., Caron, M.G. & Koller, B.H. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427-436 (1999).
28. Hoffman, D.C. & Donovan, H. Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability. Psychopharmacology (Berl.) 120, 128-133 (1995).
29. Creese, I., Burt, D.R. & Snyder, S.H. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192, 481-483 (1976).
30. Tsien, J.Z. et al. Subregion-And cell type-restricted gene knockout in mouse brain. Cell 87, 1317-1326 (1996).
31. Ungerstedt, U. & Arbuthnott, G.W. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-493 (1970).
32. Watabe-Uchida, M., Zhu, L., Ogawa, S.K., Vamanrao, A. & Uchida, N. Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 74, 858-873 (2012).
33. Sesack, S.R. & Pickel, V.M. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J. Comp. Neurol. 320, 145-160 (1992).
34. Parker, J.G., Beutler, L.R. & Palmiter, R.D. The contribution of NMDA receptor signaling in the corticobasal ganglia reward network to appetitive Pavlovian learning. J. Neurosci. 31, 11362-11369 (2011).
35. Kato, S. et al. A lentiviral strategy for highly efficient retrograde gene transfer by pseudotyping with fusion envelope glycoprotein. Hum. Gene Ther. 22, 197-206 (2011).
36. Ke, M.T., Fujimoto, S. & Imai, T. SeeDB: a simple and morphology-preserving optical clearing agent for neuronal circuit reconstruction. Nat. Neurosci. 16, 1154-1161 (2013).
37. Harnett, M.T., Makara, J.K., Spruston, N., Kath, W.L. & Magee, J.C. Synaptic amplification by dendritic spines enhances input cooperativity. Nature 491, 599-602 (2012).
38. Tonnesen, J., Katona, G., Rozsa, B. & Nagerl, U.V. Spine neck plasticity regulates compartmentalization of synapses. Nat. Neurosci. 17, 678-685 (2014).
39. Yuste, R. Electrical compartmentalization in dendritic spines. Annu. Rev. Neurosci. 36, 429-449 (2013).
40. Laruelle, M. et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. USA 93, 9235-9240 (1996).
41. Belforte, J.E. et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat. Neurosci. 13, 76-83 (2010).
42. Gainetdinov, R.R., Mohn, A.R. & Caron, M.G. Genetic animal models: focus on schizophrenia. Trends Neurosci. 24, 527-533 (2001).
43. Ballard, I.C. et al. Dorsolateral prefrontal cortex drives mesolimbic dopaminergic regions to initiate motivated behavior. J. Neurosci. 31, 10340-10346 (2011).
44. Insel, T.R. Rethinking schizophrenia. Nature 468, 187-193 (2010).
45. Lawrie, S.M. et al. Reduced frontotemporal functional connectivity in schizophrenia associated with auditory hallucinations. Biol. Psychiatry 51, 1008-1011 (2002).
46. Ford, J.M., Mathalon, D.H., Whitfield, S., Faustman, W.O. & Roth, W.T. Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol. Psychiatry 51, 485-492 (2002).
47. Yizhar, O. et al. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 477, 171-178 (2011).
48. Sun, D. et al. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr. Res. 108, 85-92 (2009).
49. McIntosh, A.M. et al. Longitudinal volume reductions in people at high genetic risk of schizophrenia as they develop psychosis. Biol. Psychiatry 69, 953-958 (2011).
50. Glausier, J.R. & Lewis, D.A. Dendritic spine pathology in schizophrenia. Neuroscience 251, 90-107 (2013).
51. Nelson, A. et al. A circuit for motor cortical modulation of auditory cortical activity. J. Neurosci. 33, 14342-14353 (2013).
52. Kim, I.H., Wang, H., Soderling, S.H. & Yasuda, R. Loss of Cdc42 leads to defects in synaptic plasticity and remote memory recall. Elife 3, e02839 (2014).
53. Kim, I.H. et al. Inositol 1, 4, 5-Trisphosphate 3-kinase a functions as a scaffold for synaptic Rac signaling. J. Neurosci. 29, 14039-14049 (2009).
54. Rossi, M.A. et al. Prefrontal cortical mechanisms underlying delayed alternation in mice. J. Neurophysiol. 108, 1211-1222 (2012).